Table 2.
Outcome | Pre-intervention (n = 213) | Trial period (n = 52) | Post-intervention (n = 220) | statistic | P |
---|---|---|---|---|---|
Door-to-needle time (min) | 73 (62–92) | 70 (60–86) | 49 (40–54)*# | 200.493 | < 0.001■ |
DNT ≤ 60 min (%) | 23.94 | 32.69 | 86.36*# | 179.190 | < 0.001▴ |
DNT ≤ 40 min (%) | 3.29 | 1.92 | 25.00*# | 51.456 | < 0.001▴ |
Door-to-CT time (min) | 25 (18–33) | 26 (20–35) | 23 (17-33) | 2.806 | 0.246■ |
Door-to-laboratory | 68 (56-79) | 65 (51–78) | 56 (47–69)*# | 34.501 | < 0.001■ |
results time (min) | |||||
Onset-to-needle time (min) | 193 (155–240) | 190 (150–234) | 167 (125–225)* | 16.618 | < 0.001■ |
90-day mRS ≤ 2(%) | 62.91 | 65.38 | 65.00 | 0.246 | 0.884▴ |
Fatality rate (%) | 7.98 | 5.77 | 5.45 | 4.624 | 0.099▴ |
Length of stay (day) | 11 (8–14) | 10 (9–13) | 11 (8–13) | 1.454 | 0.483■ |
Hospitalization expenses (yuan) | 23554.81 | 22131.67 | 25084.50 | 2.363 | 0.307■ |
p < 0.001 vs. pre-intervention;
p < 0.05 vs. trial period.
Groups were compared by Kruskal-Wallis test.
Groups were compared by χ2 test.